JP2024095819A5 - - Google Patents

Download PDF

Info

Publication number
JP2024095819A5
JP2024095819A5 JP2024065848A JP2024065848A JP2024095819A5 JP 2024095819 A5 JP2024095819 A5 JP 2024095819A5 JP 2024065848 A JP2024065848 A JP 2024065848A JP 2024065848 A JP2024065848 A JP 2024065848A JP 2024095819 A5 JP2024095819 A5 JP 2024095819A5
Authority
JP
Japan
Prior art keywords
compound
rev
erb
formula
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024065848A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024095819A (ja
Filing date
Publication date
Priority claimed from GBGB1810486.9A external-priority patent/GB201810486D0/en
Application filed filed Critical
Publication of JP2024095819A publication Critical patent/JP2024095819A/ja
Publication of JP2024095819A5 publication Critical patent/JP2024095819A5/ja
Pending legal-status Critical Current

Links

JP2024065848A 2018-06-26 2024-04-16 ナチュラルキラー細胞 Pending JP2024095819A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1810486.9 2018-06-26
GBGB1810486.9A GB201810486D0 (en) 2018-06-26 2018-06-26 Natural killer cells
PCT/GB2019/051803 WO2020002911A1 (en) 2018-06-26 2019-06-26 Natural killer cells
JP2020571746A JP7527207B2 (ja) 2018-06-26 2019-06-26 ナチュラルキラー細胞

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020571746A Division JP7527207B2 (ja) 2018-06-26 2019-06-26 ナチュラルキラー細胞

Publications (2)

Publication Number Publication Date
JP2024095819A JP2024095819A (ja) 2024-07-10
JP2024095819A5 true JP2024095819A5 (https=) 2024-10-31

Family

ID=63042803

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020571746A Active JP7527207B2 (ja) 2018-06-26 2019-06-26 ナチュラルキラー細胞
JP2024065848A Pending JP2024095819A (ja) 2018-06-26 2024-04-16 ナチュラルキラー細胞

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020571746A Active JP7527207B2 (ja) 2018-06-26 2019-06-26 ナチュラルキラー細胞

Country Status (8)

Country Link
US (1) US12377119B2 (https=)
EP (1) EP3814485A1 (https=)
JP (2) JP7527207B2 (https=)
CN (1) CN112752837A (https=)
AU (1) AU2019293163B2 (https=)
CA (1) CA3104674A1 (https=)
GB (1) GB201810486D0 (https=)
WO (1) WO2020002911A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201703476D0 (en) 2017-03-03 2017-04-19 Imp Innovations Ltd Natural killer cells
GB201810486D0 (en) * 2018-06-26 2018-08-08 Imperial Innovations Ltd Natural killer cells
AU2021372389A1 (en) * 2020-10-16 2023-05-11 Pelagos Pharmaceuticals, Inc. Rev-erb agonists
WO2024047368A1 (en) 2022-09-02 2024-03-07 Imperial College Innovations Limited Natural killer cells
GB202217507D0 (en) 2022-11-23 2023-01-04 Imperial College Innovations Ltd Natural killer cells
AU2024212529A1 (en) * 2023-01-27 2025-06-19 Opna Bio SA Compounds and methods for yap/tead modulation and indications therefor

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59141562A (ja) * 1983-02-01 1984-08-14 Nippon Kayaku Co Ltd N,n′−置換イミダゾ−ルカルボキサミド誘導体および農園芸用殺菌殺線虫剤
JPS60109568A (ja) * 1983-11-17 1985-06-15 Ube Ind Ltd イミダゾ−ル誘導体および農園芸用殺菌剤
GB9206757D0 (en) * 1992-03-27 1992-05-13 Ferring Bv Novel peptide receptor ligands
AU5845096A (en) * 1995-05-31 1996-12-18 Nissan Chemical Industries Ltd. 5-pyrazolecarboxamide derivatives and plant disease control agent
EP1001764A4 (en) * 1997-05-29 2005-08-24 Merck & Co Inc HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
WO2000046204A1 (en) 1999-02-04 2000-08-10 Sk Corporation Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
WO2003000657A1 (en) * 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
EP1442028A4 (en) * 2001-11-06 2009-11-04 Bristol Myers Squibb Co SUBSTITUTED ACID DERIVATIVES, WHICH APPRECIATE AS ANTIDIBILICS AND AGENTS AGAINST OBESITAS, AND METHODS
BR0312503A (pt) * 2002-07-09 2007-06-26 Bristol Myers Squibb Co derivados heterocìclicos substituìdos úteis como agentes antidiabéticos e antiobesidade, composição farmacêutica, uso e combinação dos mesmos
US20090062212A1 (en) 2007-05-07 2009-03-05 Elliott Richelson Peptide analogs that are potent and selective for human neurotensin preceptor subtype 2
CA3080368A1 (en) * 2009-12-04 2011-06-09 Stem Cell & Regenerative Medicine International, Inc. Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts
EP3184109B1 (en) * 2009-12-29 2020-11-18 Gamida-Cell Ltd. Methods for enhancing natural killer cell proliferation and activity
WO2012075412A1 (en) * 2010-12-03 2012-06-07 Michael Verneris Generation of natural killer cells and lymphoid tissue inducer-like (lti-like) nk-22 cells
WO2012128622A1 (en) 2011-03-18 2012-09-27 Ipd-Therapeutics B.V. Generation of nk cells and nk-cell progenitors
WO2013033310A1 (en) 2011-08-31 2013-03-07 Theodore Mark Kamenecka Modulators of rev-erb
US9175266B2 (en) * 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
CN103710304B (zh) * 2012-09-29 2018-11-02 北京东方百奥医药开发有限公司 脂肪干细胞诱导分化为自然杀伤细胞的方法及用途
ITTO20130816A1 (it) * 2013-10-09 2015-04-10 Fond Istituto Italiano Di Tecnologia Antagonisti di rev-erb diarilalchilaminici e loro uso come farmaci
WO2015103527A1 (en) 2014-01-06 2015-07-09 The Scripps Research Institute Modulators of rev-erb
GB201703476D0 (en) * 2017-03-03 2017-04-19 Imp Innovations Ltd Natural killer cells
GB201704953D0 (en) * 2017-03-28 2017-05-10 Imp Innovations Ltd Natural killer cells
WO2018178663A1 (en) * 2017-03-30 2018-10-04 Parker Hannifin Manufacturing Limited A pressure swing adsorption system with a variable flow restrictor
GB201810486D0 (en) * 2018-06-26 2018-08-08 Imperial Innovations Ltd Natural killer cells

Similar Documents

Publication Publication Date Title
JP2024095819A5 (https=)
Bari et al. Expansion and homing of umbilical cord blood hematopoietic stem and progenitor cells for clinical transplantation
JP2008517948A5 (https=)
JP2000510866A (ja) Tnfとpde―ivのインヒビターとしてのキノリンスルホンアミド
CZ20012635A3 (cs) Aromatické heterocyklické sloučeniny, způsob jejich výroby a jejich pouľití
US20260015583A1 (en) Methods for generating hematopoietic stem cells
KR102799183B1 (ko) 2-옥신돌 화합물
WO2011143802A1 (zh) 一种体外诱导巨核祖细胞和巨核细胞的方法
Katoh et al. Conversion of normal Ly‐1‐positive B‐lineage cells into Ly‐1‐positive macrophages in long‐term bone marrow cultures
KR20240008354A (ko) 인간 과립구-대식세포 전구체의 확장 방법 및 그의 적용
JP2019182880A (ja) 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の処置方法
JP2023504573A (ja) 造血幹細胞を生成するための方法
JP2003535144A5 (https=)
JP2021521262A5 (https=)
JPH04270282A (ja) 免疫抑制剤として有用な新規な炭素環状アデノシン類似体
JP7555583B2 (ja) 母児間免疫寛容を誘導する方法
CN112135618A (zh) 体内介导免疫应答的nk和dc细胞的扩增
JP2026000977A (ja) 三次元スフェロイド型細胞凝集体に由来の細胞外小胞を含む血管新生促進用組成物
CN104546819A (zh) 二咖啡酰奎宁酸在治疗系统性自身免疫性疾病中的用途
CN1323604C (zh) 藤茶黄酮微囊的制备方法
CN113582935A (zh) 一种炎症小体核苷酸结合寡聚化结构域样受体蛋白3抑制剂及其制备方法和应用
JP2008531696A5 (https=)
JPWO2024135853A5 (https=)
CN105907703B (zh) 一种诱导骨髓间充质干细胞向肝样细胞分化的方法
JPWO2023277153A5 (https=)